MSH2 and cancer: The loss of expression of any of the MLH1, MSH2, MSH6 or PMS2 proteins serves as a referral criterion to a Cancer Genetic Counseling Unit and facilitates the targeted genetic diagnostic evaluation for LS [122,123].